Use of cholinesterase inhibitors for treatment of Alzheimer disease. (Record no. 11381428)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01182 a2200325 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514003710.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200108s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0891-1150 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.3949/ccjm.68.7.608 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hake, A M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20010802 |
245 00 - TITLE STATEMENT | |
Title | Use of cholinesterase inhibitors for treatment of Alzheimer disease. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cleveland Clinic journal of medicine |
Date of publication, distribution, etc. | Jul 2001 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 608-9, 613-4, 616 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alzheimer Disease |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carbamates |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cholinesterase Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Donepezil |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Galantamine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indans |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenylcarbamates |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperidines |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rivastigmine |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tacrine |
General subdivision | therapeutic use |
773 0# - HOST ITEM ENTRY | |
Title | Cleveland Clinic journal of medicine |
Related parts | vol. 68 |
-- | no. 7 |
-- | p. 608-9, 613-4, 616 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.3949/ccjm.68.7.608">https://doi.org/10.3949/ccjm.68.7.608</a> |
Public note | Available from publisher's website |
No items available.